Market Overview

After The Mass Semiconductor Downgrade, Who's Actually Outperforming?

After The Mass Semiconductor Downgrade, Who's Actually Outperforming?
Related IPHI
Semi Execs Present Optimistic View At Morgan Stanley's TMT Conference
Mid-Afternoon Market Update: Telaria Falls Following Q4 Results; Achillion Pharmaceuticals Shares Surge
Inphi -6.1% on analyst downgrade (Seeking Alpha)
Related RBCN
Stocks Hitting 52-Week Lows
Stocks Hitting 52-Week Lows

Several semiconductor-related stocks were down on Monday following Needham's bulk downgrade.

The companies affected include Ambarella Inc (NASDAQ: AMBA), Cavium Inc (NASDAQ: CAVM), RF Micro Devices, Inc. (NASDAQ: RFMD), TriQuint Semiconductor (NASDAQ: TQNT) and Skyworks Solutions Inc (NASDAQ: SWKS).

So, Is Anyone Actually Outperforming?


Inphi Corporation (NYSE: IPHI) was one of the top movers in the space on Monday; shares gained 3.6 percent.

Worth noting, Inphi was the only stock upgraded by Needham. The firm changed its rating from a Buy to a Strong Buy with a price target of $23. That implies an upside of more than 40 percent from current market prices.

Related Link: With Solar Stocks In Focus, Here's What Wall Street Is Thinking

Rubicon Technology

Rubicon Technology, Inc. (NASDAQ: RBCN) was another major gainer on Monday, though a direct reason was less clear.

The stock has been trading very close to its 52-week low in recent weeks at 0.5 times the company’s sales (versus an industry average valuation of more than 3x P/S).

Despite a 3.6 percent gain on Monday, the stock still trades below the lowest of its price targets issued in 2014. Canaccord Genuity issued a $5 target in November.

Latest Ratings for IPHI

Mar 2018Northland SecuritiesDowngradesMarket PerformUnderperform
Feb 2018Morgan StanleyMaintainsEqual-WeightEqual-Weight
Feb 2018Stifel NicolausMaintainsBuyBuy

View More Analyst Ratings for IPHI
View the Latest Analyst Ratings

Posted-In: NeedhamLong Ideas Upgrades Price Target Analyst Ratings Movers Trading Ideas Best of Benzinga


Related Articles (CAVM + AMBA)

View Comments and Join the Discussion!